Quantum-si Inc cash flow statement
In fiscal 2025, Quantum-si Inc's operations generated −$94.7m of cash; it spent $2.5m on capital projects, leaving free cash flow of −$97.2m.
Cash flow statement
| Fiscal year | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | −67 | −91 | −94 | −88 | −95 | −92 |
| Depreciation and amortisation | 1 | 3 | 4 | 5 | 4 | 5 |
| Stock-based pay | 25 | 11 | 9 | 9 | 11 | 11 |
| Capital spending | 6 | 11 | 5 | 5 | 3 | 1 |
| Free cash flow | −73 | −101 | −99 | −92 | −97 | −94 |
| Free cash flow after stock pay | −97 | −113 | −107 | −101 | −108 | −105 |
| Shares issued | — | 0 | 0 | 35 | 0 | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −23 | −23 | −26 | −20 | −32 | −16 | −26 | −18 |
| Depreciation and amortisation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Stock-based pay | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 |
| Capital spending | 1 | 1 | 1 | 0 | 1 | −0 | 0 | 0 |
| Free cash flow | −24 | −24 | −27 | −21 | −33 | −16 | −26 | −19 |
| Free cash flow after stock pay | −27 | −27 | −30 | −23 | −36 | −19 | −28 | −22 |
| Shares issued | — | — | 47 | 0 | — | — | — | — |
Compare with peers
- Bionexus Gene Lab Corp cash flow
- YD Bio Ltd cash flow
- Ispecimen Inc. cash flow
- Seer, Inc. cash flow
- Bionano Genomics, Inc. cash flow
Head to head: BGLC vs QSIQSI vs YDESISPC vs QSI
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies